Oxford Science Enterprises' Portfolio Company OxfordVR to Combine with BehaVR to Confront the Mental Health Crisis with the Largest VR Delivery Platform for Evidence-Based Digital Therapeutics

Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, today announces its Health Tech portfolio company OxfordVR, a leader in virtual reality (VR) treatments for serious mental ...

Related Keywords

United Kingdom ,Daniel Freeman ,Alexis Zervoglos ,Deepak Gopalakrishna ,Health Tech ,Department Of Psychology ,University Of Oxford ,Oxford Science Enterprises ,World Health Organization ,Senior Partner Tech At Oxford Science Enterprises ,Professor Daniel Freeman ,Breakthrough Device ,Drug Administration ,Senior Partner ,